Erratum: FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells (PLoS ONE (2013) 8:5 DOI: 10.1371/journal.pone.0063641);FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ren, Shun X ^a   Shen, Jin ^a   Cheng, Alfred S L ^a   Lu, Lan ^a   Chan, Ruby L Y ^a   Li, Zhi J ^a   Wang, Xiao J ^a   Wong, Clover C M ^a   Zhang, Lin ^a   Ng, Simon S M ^a   Chan, Franky L ^a   Chan, Francis K L ^a   Yu, Jun ^a   Sung, Joseph J Y ^a   Wu, William K K ^a   Cho, Chi H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; CASPASE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ENDONUCLEASE G; FK 16; PEPTIDES AND PROTEINS; PROTEIN BAX; PROTEIN BCL 2; PROTEIN LC3 I; PROTEIN LC3 II; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL CULTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; UPREGULATION;

EID: 84877887193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131750     Document Type: Erratum

References (50)

1. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
2. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL, (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526.
3. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B, (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273: 3718-3724.
4. Melo MN, Ferre R, Castanho MA, (2009) Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 7: 245-250.
5. Schroder-Borm H, Bakalova R, Andra J, (2005) The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett 579: 6128-6134.
6. Hoskin DW, Ramamoorthy A, (2006) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778: 357-375.
7. Mader JS, Salsman J, Conrad DM, Hoskin DW, (2005) Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther 4: 612-624.
8. Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, et al. (2006) Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur Urol 50: 141-147.
9. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, et al. (2006) Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 66: 8542-8549.
10. Wang G, Li X, Wang Z, (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37: D933-937.
11. Dürr UH, Sudheendra US, Ramamoorthy A, (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758: 1408-1425.
12. Braff MH, Gallo RL, (2006) Antimicrobial peptides: an essential component of the skin defensive barrier. Curr Top Microbiol Immunol 306: 91-110.
13. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111: 1665-1672.
14. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, et al. (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176: 2455-2464.
15. Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, et al. (2010) Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer 127: 1741-1747.
16. Mader JS, Mookherjee N, Hancock RE, Bleackley RC, (2009) The human host defense peptide LL-37 induces apoptosis in a calpain- and apoptosis-inducing factor-dependent manner involving Bax activity. Mol Cancer Res 7: 689-702.
17. Wu WK, Sung JJ, To KF, Yu L, Li HT, et al. (2010) The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells. J Cell Physiol 223: 178-186.
18. Li X, Li Y, Han H, Miller DW, Wang G, (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc 128: 5776-5785.
19. Ren SX, Cheng AS, To KF, Tong JH, Li MS,et al. (In press) Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. Cancer Res doi:10.1158/0008-5472.CAN-12-2359.
20. Moon JY, Henzler-Wildman KA, Ramamoorthy A, (2006) Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim Biophys Acta 1758: 1351-1358.
21. Wang G, (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283: 32637-32643.
22. Ramamoorthy A, Lee DK, Santos JS, Henzler-Wildman KA, (2008) Nitrogen-14 solid-state NMR spectroscopy of aligned phospholipid bilayers to probe peptide-lipid interaction and oligomerization of membrane associated peptides. J Am Chem Soc 130: 11023-11029.
23. Henzler Wildman KA, Lee DK, Ramamoorthy A, (2003) Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42: 6545-6558.
24. Henzler-Wildman KA, Martinez GV, Brown MF, Ramamoorthy A, (2004) Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry 43: 8459-8469.
25. Porcelli F, Verardi R, Shi L, Henzler-Wildman KA, Ramamoorthy A, et al. (2008) NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 47: 5565-5572.
26. Thennarasu S, Tan A, Penumatchu R, Shelburne CE, Heyl DL, et al. (2010) Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys J 98: 248-257.
27. Li X, Li Y, Han H, Miller DW, Wang G, (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc 128: 5776-5785.
28. Wang G, (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283: 32637-32643.
29. Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, et al. (2008) No death without life: vital functions of apoptotic effectors. Cell Death Differ 15: 1113-1123.
30. Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee CW, et al. (2012) The autophagic paradox in cancer therapy. Oncogene 31: 939-953.
31. Levine B, Abrams J, (2008) p53: The Janus of autophagy? Nat Cell Biol 10: 637-639.
32. Strauss G, Westhoff MA, Fischer-Posovszky P, Fulda S, Schanbacher M, et al. (2008) 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG. Cell Death Differ 15: 332-343.
33. Qiao L, Wong BC, (2009) Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Updat 12: 55-64.
34. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
35. Wang W, El-Deiry WS, (2008) Restoration of p53 to limit tumor growth. Curr Opin Oncol 20: 90-96.
36. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
37. Nakano K, Vousden KH, (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694.
38. Lee JH, Jeong YJ, Lee SW, Kim D, Oh SJ, et al. (2010) EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer lett. 290: 68-75.
39. Lorin S, Pierron G, Ryan KM, Codogno P, Djavaheri-Mergny M, (2010) Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy. Autophagy 6: 153-154.
40. Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, et al. (2007) Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res 67: 6314-6324.
41. Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, et al. (2009) Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 119: 1359-1372.
42. Shen S, Kepp O, Kroemer G, (2012) The end of autophagic cell death? Autophagy 8: 1-3.
43. Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, et al. (2008) A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 14: 90-102.
44. Kaminskyy V, Piskunova T, Zborovskaya I, Tchevkina E, Zhivotovsky B, (2012) Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and-independent apoptosis by stimulating ROS formation. Autophagy 8: 1032-1044.
45. Rashmi R, Pillai SG, Vijayalingam S, Ryerse J, Chinnadurai G, (2008) BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene 27: 1366-1375.
46. Steiger-Barraissoul S, Rami A, (2009) Serum deprivation induced autophagy and predominantly an AIF-dependent apoptosis in hippocampal HT22 neurons. Apoptosis 14: 1274-1288.
47. Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, Laharanne E, et al. (2011) Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. Cancer Biol Ther 11: 1017-1027.
48. Zheng F, Yang WJ, Sun KJ, Wan XM, Man N, et al. (2012) Hoechst 33342-induced autophagy protected HeLa cells from caspase-independent cell death with the participation of ROS. Free Radic Res 46: 740-749.
49. Song KS, Kim JS, Yun EJ, Kim YR, Seo KS, et al. (2008) Rottlerin induces autophagy and apoptotic cell death through a PKC-delta-independent pathway in HT1080 human fibrosarcoma cells: the protective role of autophagy in apoptosis. Autophagy 4: 650-658.
50. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B, (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290: 989-992.